Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05011_nanopub.RA4eXFhDz2dtTXZSiJYiKJuxqNLM-ujtUi8uXXbmfalD4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05011 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05011 label "EG004 [drugbank:DB05011]" assertion.
- drugbank:DB05011 seeAlso DB05011 assertion.
- drugbank:DB05011 description "EG004 is a novel product consisting of a local delivery device and a gene-based medicine, being developed to prevent the blocking of veins and arteries that frequently occurs after vascular surgery. The initial target market is haemodialysis graft access surgery, a procedure in which patients whose kidneys have failed have a plastic tube grafted between blood vessels generally in their forearm so that their blood can be regularly filtered using a dialysis machine. EG004 has completed a Phase II trial, this being the first part of the Phase II/III study for which it has received approval from the US Recombinant DNA Advisory Committee (RAC)." assertion.
- drugbank:DB05011 identifier "drugbank:DB05011" assertion.
- drugbank:DB05011 title "EG004" assertion.
- drugbank:DB05011 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05011 drugbank_vocabulary:drugbank-id "DB05011" assertion.
- drugbank:DB05011 bio2rdf_vocabulary:x-identifiers.org DB05011 assertion.
- drugbank:DB05011 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05011" assertion.
- drugbank:DB05011 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05011 bio2rdf_vocabulary:identifier "DB05011" assertion.